Lettmann Jason bought ALXO
October 14, 2025 · Form 4 insider transaction
Lettmann Jason bought 597,500 shares of ALX Oncology Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
597,500
Price
$0.00
Total value
N/A
InsiderLettmann Jason
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 14, 2025
Filing dateOctober 16, 2025
Shares owned after597,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026.